These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13765470)

  • 1. [Radiological aspects and course of metastatic bone lesions due to breast neoplasms in patients treated with an enolic derivative of testosterone without androgenic activity].
    MAINOLDI F; BERNARDI L
    Radiol Med; 1961 Jun; 47():530-41. PubMed ID: 13765470
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate.
    MAXFIELD JR; MAXFIELD JG; MAXFIELD WS
    South Med J; 1958 Mar; 51(3):320-7. PubMed ID: 13529242
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of secondary deposits in bone from carcinoma of the breast with radio-active phosphorus and Durabolin.
    RIORDAN DJ; BROWNE PA
    J Ir Med Assoc; 1961 Aug; 49():40-4. PubMed ID: 13741800
    [No Abstract]   [Full Text] [Related]  

  • 4. COMBINED ESTROGENIC AND ANDROGENIC HORMONE THERAPY IN ADVANCED BREAST CANCER.
    KENNEDY BJ; BROWN JH
    Cancer; 1965 Apr; 18():431-5. PubMed ID: 14278039
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival time in women with disseminated breast cancer, following testosterone treatment.
    HALLBERG O; NOHRMAN B; SYLVEN B
    Acta Radiol (Stockh); 1953 Feb; 39(2):161-8. PubMed ID: 13040067
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of testosterone on patients with bone metastases; a metabolic study, particularly of breast carcinoma.
    LASZLO D; SCHILLING A; BELLIN J; GOTTESMAN ED; SCHULMAN CA
    J Am Med Assoc; 1952 Apr; 148(17):1502-7. PubMed ID: 14917540
    [No Abstract]   [Full Text] [Related]  

  • 7. The hormone treatment of advanced breast cancer: comparative therapy with testosterone and two experimental androgens.
    LEWISON EF; GROW JL; TRIMBLE FH
    Am Surg; 1960 Apr; 26():278-83. PubMed ID: 14416562
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of enolic derivatives of testosterone, in combination with radiotherapy, in patients with metastasizing neoplasms of the breast and of the genital area].
    SIGHINOLFI R
    Policlinico Prat; 1962 Apr; 69():532-40. PubMed ID: 14039271
    [No Abstract]   [Full Text] [Related]  

  • 9. CALCIUM AND PHOSPHATE METABOLISM IN PATIENTS WITH DISSEMINATED BREAST CANCER: EFFECT OF ANDROGENS AND OF PREDNISONE.
    GARDNER B; GRAHAM WP; GORDAN GS; LOKEN HF; THOMAS AN; TEAL JS
    J Clin Endocrinol Metab; 1963 Nov; 23():1115-24. PubMed ID: 14084130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences in the treatment of metastases from breast carcinoma with an enolic derivative of dihydrotestosterone].
    CHELI C
    Minerva Med; 1962 May; 53():1591-5. PubMed ID: 13878587
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast.
    HOMBURGER F; KASDON SC; FISHMAN WH
    Proc Soc Exp Biol Med; 1950 May; 74(1):162-4. PubMed ID: 15430420
    [No Abstract]   [Full Text] [Related]  

  • 12. [RARE CASE OF BONE METASTASIS OF BREAST CANCER].
    ADACHI T; OKUYAMA T; MITOMO Y
    Rinsho Hoshasen; 1963 Nov; 8():861-7. PubMed ID: 14095589
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of testosterone propionate on metastases to bone from carcinoma of the breast.
    PRESTON FW; TAYLOR SG; CRUMRINE JL
    J Clin Endocrinol Metab; 1949 Dec; 9(12):1314-23, illust. PubMed ID: 15399549
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone therapy in metastatic lesions of mammary cancer.
    BAUMANN F; O'CONNOR KL
    J Am Med Womens Assoc; 1949 Dec; 4(12):516-9, illust. PubMed ID: 15408317
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake on radiosulfate in growing bones of cockerels treated with cortisone and certain anabolic-androgenic steroids.
    KOWALEWSKI K
    Endocrinology; 1958 Dec; 63(6):759-64. PubMed ID: 13609547
    [No Abstract]   [Full Text] [Related]  

  • 16. [Androgenic and anabolic activity of a new enolic derivative of testosterone active by oral route. Clinical research].
    BUTTURINI U
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13():765-78. PubMed ID: 13689496
    [No Abstract]   [Full Text] [Related]  

  • 17. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort.
    Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH
    Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE MAGIC 6,000.
    EVANS JC
    Radiol Clin; 1964; 33():34-8. PubMed ID: 14128506
    [No Abstract]   [Full Text] [Related]  

  • 19. [OSTEOPLASTIC CHANGES INDUCED BY ANABOLIC STEROIDS AND OTHER THERAPEUTIC METHODS IN ROENTGENOLOGICALLY UNVERIFIED OSTEOCLASTIC BONE METASTASES FROM BREAST CANCER].
    RIESSBECK KH
    Z Gesamte Inn Med; 1964 Oct; 19():751-5. PubMed ID: 14231673
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectacular effect of testosterone propionate on mammary cancer metastases; case report.
    KIRKETERP P
    Acta Radiol (Stockh); 1952; 37(3-4):282-3. PubMed ID: 14933206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.